Vault-13

PROTAGENIC THERAPEUTICS INC PTIX

COM NEW · Common Stock · CUSIP 74365N202

12 institutional holders +0 vs Q1 2024
159,785159.8k shares reported held*
$145.7kreported value*
2 new 3 added 1 reduced 2 sold out net sold ≈ $343.1k (-377.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.91.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

051015Q1 23: 10Q2 23: 11Q3 23: 10Q4 23: 11Q1 24: 12Q2 24: 1212Q1 23Q2 23Q3 23Q4 23Q1 24Q2 24
Numbers
QuarterHolders
Q1 202310
Q2 202311
Q3 202310
Q4 202311
Q1 202412
Q2 202412

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
505Q2 23: 4 bought or addedQ2 23: 2 cut or sold outQ2 23Q3 23: 3 bought or addedQ3 23: 1 cut or sold outQ3 23Q4 23: 5 bought or addedQ4 23: 0 cut or sold outQ4 23Q1 24: 4 bought or addedQ1 24: 3 cut or sold outQ1 24Q2 24: 5 bought or addedQ2 24: 3 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q2 202342
Q3 202331
Q4 202350
Q1 202443
Q2 202453

Biggest buyers

Biggest sellers

EAGLE ASSET MANAGEMENT INC Sold out -419,324-419.3k
WELLS FARGO & COMPANY/MN Sold out -27-27
MORGAN STANLEY Reduced -2-2

Insider purchases and sales in Q2 2024

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
101Q3 22: 0 buyingQ3 22: 0 sellingQ4 22: 0 buyingQ4 22: 0 sellingQ4 22Q1 23: 0 buyingQ1 23: 0 sellingQ2 23: 0 buyingQ2 23: 0 sellingQ2 23Q3 23: 0 buyingQ3 23: 0 sellingQ4 23: 1 buyingQ4 23: 0 sellingQ4 23Q1 24: 0 buyingQ1 24: 0 sellingQ2 24: 0 buyingQ2 24: 0 sellingQ2 24
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20220—0——
Q4 20220—0——
Q1 20230—0——
Q2 20230—0——
Q3 20230—0——
Q4 20231$6.5k0——
Q1 20240—0——
Q2 20240—0——

None reported in Q2 2024.

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 VANGUARD GROUP INC 0.00% of their portfolio Valley Forge, PA 33,16633.2k $30.0k $30.0k 0.00% Unchanged
2 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 29,13029.1k $26.8k $26.8k 0.00% Added +4.0k +3,956
3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 26,59826.6k $24.4k $24.4k 0.00% New
4 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 21,41421.4k $19.5k $19.5k 0.00% Unchanged
5 FNY Investment Advisers, LLC 0.01% of their portfolio NEW YORK, NY 18,75018.8k $17.0k $17.0k 0.01% Unchanged
6 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 13,81213.8k $12.7k $12.7k 0.00% Unchanged
7 UBS Group AG 0.00% of their portfolio ZURICH, V8 10,07810.1k $9.1k $9.1k 0.00% New
8 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 6,8066.8k $6.2k $6.2k 0.00% Added +993 +993
9 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 2929 $26 $26 0.00% Added +28 +28
10 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 11 $1 $1 0.00% Reduced -2 -2
11 CWM, LLC 0.00% of their portfolio OMAHA, NE 11 $0 $0 0.00% Unchanged
12 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged